CH649989A5 - Substituierte n-anilino-4-chlor-3-sulfamoylbenzamide. - Google Patents
Substituierte n-anilino-4-chlor-3-sulfamoylbenzamide. Download PDFInfo
- Publication number
- CH649989A5 CH649989A5 CH5145/82A CH514582A CH649989A5 CH 649989 A5 CH649989 A5 CH 649989A5 CH 5145/82 A CH5145/82 A CH 5145/82A CH 514582 A CH514582 A CH 514582A CH 649989 A5 CH649989 A5 CH 649989A5
- Authority
- CH
- Switzerland
- Prior art keywords
- chloro
- substituted
- general formula
- sulfamoylbenzamides
- anilino
- Prior art date
Links
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 230000010933 acylation Effects 0.000 claims description 5
- 238000005917 acylation reaction Methods 0.000 claims description 5
- 150000002429 hydrazines Chemical class 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- SCYSJFKWFQZRJW-UHFFFAOYSA-N 4-chloro-3-sulfamoylbenzoyl chloride Chemical compound NS(=O)(=O)C1=CC(C(Cl)=O)=CC=C1Cl SCYSJFKWFQZRJW-UHFFFAOYSA-N 0.000 claims description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 4
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 3
- -1 4-chloro-3-sulfamoylbenzoic acid halide Chemical class 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- QWNNFYQUBPILCG-UHFFFAOYSA-N metipamide Chemical compound C=1C=CC=CC=1N(C)NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 QWNNFYQUBPILCG-UHFFFAOYSA-N 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- KAPJGZDRPBUZMF-UHFFFAOYSA-N 5-(anilinocarbamoyl)-2-chlorobenzenesulfonamide Chemical class C1=C(Cl)C(S(=O)(=O)N)=CC(C(=O)NNC=2C=CC=CC=2)=C1 KAPJGZDRPBUZMF-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000012433 hydrogen halide Substances 0.000 claims 1
- 229910000039 hydrogen halide Inorganic materials 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002934 diuretic Substances 0.000 description 6
- 230000001882 diuretic effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000000894 saliuretic effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- NDDAHWYSQHTHNT-UHFFFAOYSA-N indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 description 3
- 229960004569 indapamide Drugs 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- NQSIARGGPGHMCG-UHFFFAOYSA-N 1-ethyl-1-phenylhydrazine Chemical compound CCN(N)C1=CC=CC=C1 NQSIARGGPGHMCG-UHFFFAOYSA-N 0.000 description 1
- MWOODERJGVWYJE-UHFFFAOYSA-N 1-methyl-1-phenylhydrazine Chemical compound CN(N)C1=CC=CC=C1 MWOODERJGVWYJE-UHFFFAOYSA-N 0.000 description 1
- XKQKCGDIIVQYKP-UHFFFAOYSA-N 2-chloro-5-(hydrazinecarbonyl)benzenesulfonamide Chemical class NNC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 XKQKCGDIIVQYKP-UHFFFAOYSA-N 0.000 description 1
- MOULQPGXSGVJOS-UHFFFAOYSA-N 2-chloro-5-[(N,4-dimethylanilino)carbamoyl]benzenesulfonamide Chemical compound CN(C1=CC=C(C=C1)C)NC(C1=CC(=C(C=C1)Cl)S(N)(=O)=O)=O MOULQPGXSGVJOS-UHFFFAOYSA-N 0.000 description 1
- OKKVBSAIAFLLCS-UHFFFAOYSA-N 2-chloro-5-[(N-phenylanilino)carbamoyl]benzenesulfonamide Chemical compound NS(=O)(=O)C1=C(Cl)C=CC(=C1)C(=O)NN(C1=CC=CC=C1)C1=CC=CC=C1 OKKVBSAIAFLLCS-UHFFFAOYSA-N 0.000 description 1
- XUYCGRVSLQWSNY-UHFFFAOYSA-N 2-chloro-5-[(n-propan-2-ylanilino)carbamoyl]benzenesulfonamide Chemical compound C=1C=CC=CC=1N(C(C)C)NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 XUYCGRVSLQWSNY-UHFFFAOYSA-N 0.000 description 1
- OYNAHVKIPRBYNQ-UHFFFAOYSA-N 2-chloro-5-[[N-(2-hydroxyethyl)anilino]carbamoyl]benzenesulfonamide Chemical compound OCCN(C1=CC=CC=C1)NC(C1=CC(=C(C=C1)Cl)S(N)(=O)=O)=O OYNAHVKIPRBYNQ-UHFFFAOYSA-N 0.000 description 1
- FHQAWINGVCDTTG-UHFFFAOYSA-N 4-chloro-3-sulfamoylbenzoic acid Chemical compound NS(=O)(=O)C1=CC(C(O)=O)=CC=C1Cl FHQAWINGVCDTTG-UHFFFAOYSA-N 0.000 description 1
- LBXHRAWDUMTPSE-AOOOYVTPSA-N 4-chloro-N-[(2S,6R)-2,6-dimethyl-1-piperidinyl]-3-sulfamoylbenzamide Chemical compound C[C@H]1CCC[C@@H](C)N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 LBXHRAWDUMTPSE-AOOOYVTPSA-N 0.000 description 1
- TYMNDUDCLLLNOV-UHFFFAOYSA-N 5-[amino(phenyl)carbamoyl]-2-chlorobenzenesulfonamide Chemical class C=1C=CC=CC=1N(N)C(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 TYMNDUDCLLLNOV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VPGRYOFKCNULNK-ACXQXYJUSA-N Deoxycorticosterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)COC(=O)C)[C@@]1(C)CC2 VPGRYOFKCNULNK-ACXQXYJUSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241001147183 Nectomys Species 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960004070 clopamide Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000926 not very toxic Toxicity 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C301/00—Esters of sulfurous acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS816459A CS220569B1 (en) | 1981-09-01 | 1981-09-01 | Substituted n-aniline-4-chloro-3-sulphamoylbenzamides and method of preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH649989A5 true CH649989A5 (de) | 1985-06-28 |
Family
ID=5411672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH5145/82A CH649989A5 (de) | 1981-09-01 | 1982-08-30 | Substituierte n-anilino-4-chlor-3-sulfamoylbenzamide. |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS5859961A (enrdf_load_stackoverflow) |
| CA (1) | CA1187899A (enrdf_load_stackoverflow) |
| CH (1) | CH649989A5 (enrdf_load_stackoverflow) |
| CS (1) | CS220569B1 (enrdf_load_stackoverflow) |
| DE (1) | DE3229453A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2512018B1 (enrdf_load_stackoverflow) |
| GB (1) | GB2104891B (enrdf_load_stackoverflow) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3088873A (en) * | 1960-02-16 | 1963-05-07 | British Drug Houses Ltd | 4-chloro-3-sulphamyl benzoic acid and salts |
| US3043874A (en) * | 1960-05-09 | 1962-07-10 | Parke Davis & Co | 4-halo-3-sulfamoylbenzoic acid derivatives and methods for producing same |
| DE1181712B (de) * | 1960-06-15 | 1964-11-19 | Ndoz A G S | Verfahren zur Herstellung von 3-Sulfamyl-4-halogen-benzoylhydrazinen |
| GB1406882A (en) * | 1972-04-28 | 1975-09-17 | Leo Pharm Prod Ltd | Benzoic acid derivatives and benzisptjoaup'e 1.1 dopxode derovatoves |
| US4258059A (en) * | 1978-12-15 | 1981-03-24 | Usv Pharmaceutical Corporation | Amino-benzamides |
-
1981
- 1981-09-01 CS CS816459A patent/CS220569B1/cs unknown
-
1982
- 1982-07-23 FR FR828212899A patent/FR2512018B1/fr not_active Expired
- 1982-07-26 GB GB08221558A patent/GB2104891B/en not_active Expired
- 1982-08-06 DE DE19823229453 patent/DE3229453A1/de active Granted
- 1982-08-25 CA CA000410121A patent/CA1187899A/en not_active Expired
- 1982-08-30 CH CH5145/82A patent/CH649989A5/de not_active IP Right Cessation
- 1982-09-01 JP JP57150823A patent/JPS5859961A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE3229453A1 (de) | 1983-03-10 |
| DE3229453C2 (enrdf_load_stackoverflow) | 1988-07-28 |
| FR2512018B1 (fr) | 1985-07-26 |
| CS220569B1 (en) | 1983-04-29 |
| GB2104891A (en) | 1983-03-16 |
| GB2104891B (en) | 1985-05-01 |
| FR2512018A1 (fr) | 1983-03-04 |
| CA1187899A (en) | 1985-05-28 |
| JPS5859961A (ja) | 1983-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0042592B1 (de) | N-Heteroaryl-alkylendiamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
| EP2504334B1 (de) | Verfahren zur reinigung von methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamat | |
| EP0041215A2 (de) | Imidazoazolalkensäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln | |
| EP0028765A1 (de) | Alkylharnstoffderivate zur Behandlung von Erkrankungen des Fettstoffwechsels; Verfahren zu deren Herstellung, deren Verwendung in Arzneimitteln zur Behandlung von Fettstoffwechselstörungen, diese enthaltende Arzneimittel, Verfahren zur Herstellung der Arzneimittel sowie einige Alkylharnstoffverbindungen | |
| EP0000741B1 (de) | Indolacetoxyacetylaminosäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittel | |
| DE2524277A1 (de) | Neue 1,4-dihydropyridine und verfahren zu ihrer herstellung | |
| DE2530577A1 (de) | Neue organische verbindungen, ihre herstellung und verwendung | |
| EP0018360B1 (de) | N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung | |
| EP0665228A1 (de) | Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel | |
| DE3877036T2 (de) | Biologisch aktive verbindungen. | |
| DE69326111T2 (de) | Hydantoinderivate, deren Salze und diese enthaltende Maillard-Reaktionsinhibitoren | |
| CH649989A5 (de) | Substituierte n-anilino-4-chlor-3-sulfamoylbenzamide. | |
| DE1142599B (de) | Verfahren zur Herstellung von Carbaminsaeureestern | |
| DE1695804C3 (de) | N Acyl 2 methyl 3 lndolylcarbon sauren, Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE3242204A1 (de) | Verfahren zur herstellung von aminoalkylfuranen oder -thiophenen | |
| AT319960B (de) | Verfahren zur Herstellung von neuen Pyridazinverbindungen | |
| DE3109532C2 (de) | Stereoisomere 1,4;3,6-Dianhydro-2,5-diazido-2,5-didesoxyhexite, Verfahren zur Herstellung derselben und diese Verbindungen enthaltende Arzneimittel | |
| AT273972B (de) | Verfahren zur Herstellung von neuen 1-(2-Aminophenyl)-1,2,3,4-tetrahydroisochinolinen sowie von deren Salzen | |
| AT234715B (de) | Verfahren zur Herstellung von neuen Carbaminsäureestern | |
| EP0108981B1 (de) | Semicarbazide, ihre Herstellung und Verwendung | |
| AT278808B (de) | Verfahren zur Herstellung neuer 4-Acyl-3,4-dihydro-2(1H)-chinoxalinonderivate | |
| CH650787A5 (de) | Oxazaphosphorine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| EP0233173A1 (de) | 1-[3-(2-Hydroxy-3-alkylamino-propoxy)-2-thienyl]-3-phenyl-1-propanone und ihre Säureadditionssalze sowie Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
| AT272307B (de) | Verfahren zur Herstellung von neuen Amidinen und ihren Säureadditionssalzen | |
| EP0040685A2 (de) | Lysergsäurederivate und deren pharmazeutische Zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |